Windtree Interest Debt Per Share from 2010 to 2025

WINT Stock  USD 1.56  0.08  4.88%   
Windtree Therapeutics Interest Debt Per Share yearly trend continues to be comparatively stable with very little volatility. Interest Debt Per Share will likely drop to 83.82 in 2025. From the period from 2010 to 2025, Windtree Therapeutics Interest Debt Per Share quarterly data regression had r-value of (0.47) and coefficient of variation of  149.45. View All Fundamentals
 
Interest Debt Per Share  
First Reported
2010-12-31
Previous Quarter
88.24
Current Value
83.82
Quarterly Volatility
5.4 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Windtree Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Windtree Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 89.6 K, Interest Expense of 54.6 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 1.9 K, Dividend Yield of 0.0 or PTB Ratio of 2.67. Windtree financial statements analysis is a perfect complement when working with Windtree Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Windtree Therapeutics Correlation against competitors.
For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.

Latest Windtree Therapeutics' Interest Debt Per Share Growth Pattern

Below is the plot of the Interest Debt Per Share of Windtree Therapeutics over the last few years. It is Windtree Therapeutics' Interest Debt Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Windtree Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Interest Debt Per Share10 Years Trend
Slightly volatile
   Interest Debt Per Share   
       Timeline  

Windtree Interest Debt Per Share Regression Statistics

Arithmetic Mean3,642
Geometric Mean770.33
Coefficient Of Variation149.45
Mean Deviation4,454
Median690.09
Standard Deviation5,443
Sample Variance29.6M
Range15.1K
R-Value(0.47)
Mean Square Error24.7M
R-Squared0.22
Significance0.07
Slope(537.12)
Total Sum of Squares444.4M

Windtree Interest Debt Per Share History

2025 83.82
2024 88.24
2023 76.73
2022 58.33
2021 100.23
2020 195.3
2019 680.8

About Windtree Therapeutics Financial Statements

Windtree Therapeutics shareholders use historical fundamental indicators, such as Interest Debt Per Share, to determine how well the company is positioned to perform in the future. Although Windtree Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Windtree Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Windtree Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Interest Debt Per Share 88.24  83.82 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Windtree Stock Analysis

When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.